Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord blood-derived mesenchymal stem cells
- Development stage
- Unknown
- Lead developer
- Chinese PLA General Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Topical, Intradermal
01
Overview
Umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) are a type of multipotent stem cell therapy being investigated by the Chinese PLA General Hospital for the regeneration of sweat glands in patients with deep burn injuries. These cells are characterized by their ability to differentiate into various cell lineages and their secretion of numerous paracrine factors, including growth factors and cytokines, which promote angiogenesis, reduce inflammation, and stimulate tissue repair. In the context of severe burns where the dermis and skin appendages are destroyed, UCB-MSCs are hypothesized to facilitate the reconstruction of functional sweat gland structures, thereby restoring thermoregulatory capacity and improving the quality of life for burn survivors.
- Brand names
- Promostem
- Other names
- UCB Mesenchymal Stem CellsUmbilical Cord Blood-derived Mesenchymal Stem Cells
Beyond the preview
Go deeper on umbilical cord blood-derived mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord blood-derived mesenchymal stem cells.